DK2266500T3 - Tredimensionel vævstruktur - Google Patents

Tredimensionel vævstruktur Download PDF

Info

Publication number
DK2266500T3
DK2266500T3 DK10183373T DK10183373T DK2266500T3 DK 2266500 T3 DK2266500 T3 DK 2266500T3 DK 10183373 T DK10183373 T DK 10183373T DK 10183373 T DK10183373 T DK 10183373T DK 2266500 T3 DK2266500 T3 DK 2266500T3
Authority
DK
Denmark
Prior art keywords
tissue structure
dimensional tissue
dimensional
tissue
Prior art date
Application number
DK10183373T
Other languages
English (en)
Inventor
Hikaru Matsuda
Yoshiki Sawa
Satoshi Taketani
Shigeru Miyagawa
Original Assignee
Cellseed Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34113882&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK2266500(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Cellseed Inc filed Critical Cellseed Inc
Application granted granted Critical
Publication of DK2266500T3 publication Critical patent/DK2266500T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0658—Skeletal muscle cells, e.g. myocytes, myotubes, myoblasts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/34—Muscles; Smooth muscle cells; Heart; Cardiac stem cells; Myoblasts; Myocytes; Cardiomyocytes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
    • A61L27/3804—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells characterised by specific cells or progenitors thereof, e.g. fibroblasts, connective tissue cells, kidney cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
    • A61L27/3804—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells characterised by specific cells or progenitors thereof, e.g. fibroblasts, connective tissue cells, kidney cells
    • A61L27/3834—Cells able to produce different cell types, e.g. hematopoietic stem cells, mesenchymal stem cells, marrow stromal cells, embryonic stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
    • A61L27/3839—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells characterised by the site of application in the body
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
    • A61L27/3895—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells using specific culture conditions, e.g. stimulating differentiation of stem cells, pulsatile flow conditions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/0068—General culture methods using substrates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0657—Cardiomyocytes; Heart cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2430/00—Materials or treatment for tissue regeneration
    • A61L2430/20—Materials or treatment for tissue regeneration for reconstruction of the heart, e.g. heart valves
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2506/00—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
    • C12N2506/02—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from embryonic cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2506/00—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
    • C12N2506/13—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from connective tissue cells, from mesenchymal cells
    • C12N2506/1346—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from connective tissue cells, from mesenchymal cells from mesenchymal stem cells
    • C12N2506/1392—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from connective tissue cells, from mesenchymal cells from mesenchymal stem cells from mesenchymal stem cells from other natural sources
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2513/00—3D culture
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2523/00—Culture process characterised by temperature
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2533/00—Supports or coatings for cell culture, characterised by material
    • C12N2533/30—Synthetic polymers
    • C12N2533/40—Polyhydroxyacids, e.g. polymers of glycolic or lactic acid (PGA, PLA, PLGA); Bioresorbable polymers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2539/00—Supports and/or coatings for cell culture characterised by properties
    • C12N2539/10—Coating allowing for selective detachment of cells, e.g. thermoreactive coating

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Cell Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Botany (AREA)
  • Dermatology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Transplantation (AREA)
  • Developmental Biology & Embryology (AREA)
  • Rheumatology (AREA)
  • Cardiology (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Hematology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Hospice & Palliative Care (AREA)
  • Materials For Medical Uses (AREA)
DK10183373T 2003-08-01 2004-02-02 Tredimensionel vævstruktur DK2266500T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2003285476 2003-08-01
EP04707319.2A EP1659979B1 (en) 2003-08-01 2004-02-02 Three-dimentional tissue structure

Publications (1)

Publication Number Publication Date
DK2266500T3 true DK2266500T3 (da) 2015-04-27

Family

ID=34113882

Family Applications (2)

Application Number Title Priority Date Filing Date
DK10183361.4T DK2266499T3 (da) 2003-08-01 2004-02-02 Tredimensionel vævstruktur.
DK10183373T DK2266500T3 (da) 2003-08-01 2004-02-02 Tredimensionel vævstruktur

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DK10183361.4T DK2266499T3 (da) 2003-08-01 2004-02-02 Tredimensionel vævstruktur.

Country Status (6)

Country Link
US (2) US9587222B2 (da)
EP (3) EP2266499B1 (da)
JP (4) JP4943844B2 (da)
DK (2) DK2266499T3 (da)
ES (2) ES2540242T3 (da)
WO (1) WO2005011524A1 (da)

Families Citing this family (97)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100436577C (zh) * 2003-02-06 2008-11-26 赛尔斯德株式会社 前眼部相关细胞片、三维结构体、及它们的制造方法
EP1600498B1 (en) * 2003-02-06 2012-08-15 Cellseed Inc. Substrates for high-density cell arrays and preparation processes and uses thereof
WO2004073761A1 (ja) * 2003-02-20 2004-09-02 Cellseed Inc. 再生角膜内皮細胞シート、製造方法及びその利用方法
US9114192B2 (en) * 2004-04-25 2015-08-25 Cellseed Inc. Cultured periodontal ligament cell sheet, process for producing the same and method of use thereof
ES2693609T3 (es) 2005-02-28 2018-12-12 Cellseed Inc. Lámina de células cultivadas, método para su producción y método para su aplicación
EP1859817A4 (en) * 2005-02-28 2012-11-07 Cellseed Inc CULTIVATED CELL SHEET, PROCESS FOR PRODUCING THE SAME, AND PROCESS FOR RESTORING TISSUE USING THE SAME
WO2007001351A1 (en) * 2005-06-17 2007-01-04 Iken Tissue Therapeutics, Inc. Methods for treating ischemic tissue
WO2008074424A2 (de) * 2006-12-19 2008-06-26 Sanofi-Aventis Gene mit einem einzigen exon, die für neue bioaktive peptide kodieren
US11224635B2 (en) 2007-03-27 2022-01-18 Venturis Thereuptics, Inc. Therapeutic angiogenesis for treatment of the spine and other tissues
US8983570B2 (en) * 2007-03-27 2015-03-17 Cardiovascular Biotherapeutics, Inc. Therapeutic angiogenesis for treatment of the spine
WO2010141027A1 (en) * 2009-06-05 2010-12-09 Virginia Tech Intellectual Properties, Inc. Electromagnetic controlled biofabrication for manufactcuring of mimetic biocompatible materials
JP5378743B2 (ja) * 2008-09-30 2013-12-25 テルモ株式会社 医療用細胞シートの製造方法
JP5269629B2 (ja) * 2009-01-16 2013-08-21 オリンパス株式会社 培養容器および細胞培養方法
CA2758208A1 (en) * 2009-04-09 2010-10-14 Jordan Lancaster Cellular seeding and co-culture of a three dimensional fibroblast construct
US20130101659A1 (en) * 2009-11-13 2013-04-25 Yoshiki Sawa Cell sheet for myocardial regeneration, method of producing the same, and method of using the same
JP5667357B2 (ja) * 2009-11-30 2015-02-12 テルモ株式会社 シート状細胞培養物の製造方法
JP5702060B2 (ja) * 2009-12-01 2015-04-15 テルモ株式会社 単離されたシート状細胞培養物の製造方法
US20120308533A1 (en) * 2009-12-03 2012-12-06 Osaka University Adipocyte sheet, three-dimensional structure thereof, and method for producing the same
US8883210B1 (en) 2010-05-14 2014-11-11 Musculoskeletal Transplant Foundation Tissue-derived tissuegenic implants, and methods of fabricating and using same
US9352003B1 (en) 2010-05-14 2016-05-31 Musculoskeletal Transplant Foundation Tissue-derived tissuegenic implants, and methods of fabricating and using same
US10130736B1 (en) 2010-05-14 2018-11-20 Musculoskeletal Transplant Foundation Tissue-derived tissuegenic implants, and methods of fabricating and using same
CN102906244B (zh) 2010-07-29 2014-01-29 泰尔茂株式会社 片状细胞培养物解离装置
EP2607898B1 (en) 2010-08-17 2016-01-20 Terumo Kabushiki Kaisha Method for evaluating graft
JP5752905B2 (ja) * 2010-08-19 2015-07-22 テルモ株式会社 シート状細胞培養物の品質判定方法およびそのためのシステム、ならびにそれらに適したシート状細胞培養物
JP5757706B2 (ja) * 2010-08-25 2015-07-29 国立大学法人 岡山大学 細胞シートの製造方法
WO2012048298A2 (en) 2010-10-08 2012-04-12 Caridianbct, Inc. Methods and systems of growing and harvesting cells in a hollow fiber bioreactor system with control conditions
JP5840855B2 (ja) 2011-03-30 2016-01-06 学校法人東京女子医科大学 胚性幹細胞から心筋シートを製造する方法
US8834928B1 (en) 2011-05-16 2014-09-16 Musculoskeletal Transplant Foundation Tissue-derived tissugenic implants, and methods of fabricating and using same
TWI452138B (zh) * 2011-06-01 2014-09-11 Univ Taipei Medical 用於細胞培養及片狀細胞層脫著之支撐物及片狀細胞層脫著之方法
JPWO2012172887A1 (ja) * 2011-06-13 2015-02-23 国立大学法人大阪大学 心疾患治療薬および心疾患治療用細胞シート
JP6111013B2 (ja) * 2011-10-30 2017-04-05 株式会社セルシード 腱細胞シート及びその製造方法
US9764063B2 (en) 2012-03-15 2017-09-19 Iheart Japan Corporation Method for producing mixed cell population of cardiomyocytes and vascular cells from induced pluripotent stem cell
WO2014014119A1 (en) * 2012-07-17 2014-01-23 Kyoto University Novel cardiomyocyte marker
US9125959B1 (en) * 2012-10-17 2015-09-08 University Of South Florida Compositions and methods for reducing or preventing medical device-related infections
US20160115441A1 (en) 2013-02-28 2016-04-28 Hideaki Sakai Novel graft polymer, temperature-responsive substrate for cell culture using the same and production method therefor, as well as liquid chromatographic carrier having the novel graft polymer immobilized thereon and liquid chromatographic method using the same
WO2014148321A1 (ja) 2013-03-19 2014-09-25 学校法人東京女子医科大学 筋芽細胞を含む細胞シート積層体およびその製造方法
CN105229145B (zh) 2013-05-17 2020-08-28 泰尔茂株式会社 片状细胞培养物的制造方法
ES2714127T3 (es) * 2013-10-24 2019-05-27 Tokyo Metropolitan Geriatric Hospital And Inst Of Gerontology Células madre musculares o mioblastos, procedimiento de cribado de sustancias que participan en la conversión metabólica usando las mismas, y composición farmacéutica que comprende la sustancia obtenida de dicho procedimiento del cribado
EP3068867B1 (en) 2013-11-16 2018-04-18 Terumo BCT, Inc. Expanding cells in a bioreactor
JP6791751B2 (ja) 2014-02-26 2020-11-25 テルモ株式会社 目的細胞の純度が高い細胞集団の製造方法
JP5802298B2 (ja) 2014-03-25 2015-10-28 テルモ株式会社 凍結保存細胞からの生細胞の回収方法およびシステム
WO2015148704A1 (en) 2014-03-25 2015-10-01 Terumo Bct, Inc. Passive replacement of media
JP6837333B2 (ja) * 2014-03-27 2021-03-03 テルモ株式会社 シート状細胞培養物を製造するための細胞培養器具およびそれを用いたシート状細胞培養物の製造方法
JP6574165B2 (ja) * 2014-03-27 2019-09-11 テルモ株式会社 シート状細胞培養物を製造するための細胞培養器具およびそれを用いたシート状細胞培養物の製造方法
US9808336B2 (en) 2014-05-02 2017-11-07 University Of Houston System Two stage cellularization strategy for the fabrication of bioartificial hearts
JP6495603B2 (ja) 2014-09-03 2019-04-03 テルモ株式会社 シート状細胞培養物とフィブリンゲルとの積層体の製造方法
JP6599089B2 (ja) * 2014-09-03 2019-10-30 テルモ株式会社 補強部を有するシート状細胞培養物とフィブリンゲルとの積層体
JP6494957B2 (ja) * 2014-09-03 2019-04-03 テルモ株式会社 シート状細胞培養物回収システムおよび方法
CN106715676A (zh) 2014-09-26 2017-05-24 泰尔茂比司特公司 按计划供养
JP7180965B2 (ja) 2014-11-12 2022-11-30 テルモ株式会社 心筋細胞シート
EP3023059A1 (en) * 2014-11-18 2016-05-25 Samsung Medison Co., Ltd. Ultrasound imaging apparatus and method of controlling the same
JP5727665B2 (ja) * 2014-12-11 2015-06-03 テルモ株式会社 シート状細胞培養物の製造方法
WO2016104666A1 (ja) 2014-12-26 2016-06-30 テルモ株式会社 液体移送方法
JP6130868B2 (ja) * 2015-02-19 2017-05-17 テルモ株式会社 単離されたシート状細胞培養物の製造方法
JP6621245B2 (ja) * 2015-03-27 2019-12-18 大日本印刷株式会社 制御された微細構造を含む三次元構造を有する人工組織の作製方法
EP3246697B1 (en) 2015-03-30 2022-06-01 Terumo Kabushiki Kaisha Method and system for producing a sheetlike cell culture
JP5893786B2 (ja) * 2015-04-02 2016-03-23 テルモ株式会社 シート状細胞培養物の製造方法
CA3177726A1 (en) 2015-05-21 2016-11-24 Musculoskeletal Transplant Foundation Modified demineralized cortical bone fibers
CA2986744A1 (en) * 2015-05-21 2016-11-24 University Of South Florida Cell culture substrate for rapid release and re-plating
JP6159365B2 (ja) * 2015-06-11 2017-07-05 テルモ株式会社 医療用細胞シートの製造方法
WO2017004592A1 (en) 2015-07-02 2017-01-05 Terumo Bct, Inc. Cell growth with mechanical stimuli
US11111375B2 (en) 2015-10-05 2021-09-07 The Regents Of The University Of California Compositions and methods for generating oligodendrocyte precursors
JPWO2017073794A1 (ja) * 2015-10-30 2018-08-16 国立大学法人京都大学 多能性幹細胞から３次元の心筋組織を製造する方法
JP6140322B2 (ja) * 2016-02-24 2017-05-31 テルモ株式会社 シート状細胞培養物の製造方法
JP6869228B2 (ja) 2016-03-28 2021-05-12 テルモ株式会社 液体中の脆弱物の形状を保持する方法およびデバイス
US11965175B2 (en) 2016-05-25 2024-04-23 Terumo Bct, Inc. Cell expansion
US11685883B2 (en) 2016-06-07 2023-06-27 Terumo Bct, Inc. Methods and systems for coating a cell growth surface
US11104874B2 (en) 2016-06-07 2021-08-31 Terumo Bct, Inc. Coating a bioreactor
SG11201805456WA (en) 2016-11-01 2019-05-30 Terumo Corp Modification method for sheet-shaped cell culture
WO2018097228A1 (ja) 2016-11-25 2018-05-31 テルモ株式会社 生細胞または生細胞を含む組成物の保存液
JP6843599B2 (ja) * 2016-11-25 2021-03-17 テルモ株式会社 生細胞または生細胞を含む組成物の保存液
WO2018097225A1 (ja) 2016-11-25 2018-05-31 テルモ株式会社 生細胞または生細胞を含む組成物の保存液
JP7045723B2 (ja) 2017-03-06 2022-04-01 学校法人東京女子医科大学 Ｌｙｐｄ１阻害剤及びそれを用いた生体組織の製造方法
US11624046B2 (en) 2017-03-31 2023-04-11 Terumo Bct, Inc. Cell expansion
WO2018184028A2 (en) 2017-03-31 2018-10-04 Terumo Bct, Inc. Cell expansion
JP6490738B2 (ja) * 2017-04-28 2019-03-27 テルモ株式会社 シート状細胞培養物の製造方法
WO2018218049A1 (en) * 2017-05-25 2018-11-29 The Regents Of The University Of California Methods of identifying equine immune-mediated myositis
SG11201912185XA (en) 2017-06-16 2020-01-30 Avery Therapeutics Inc Three dimensional tissue compositions and methods of use
JPWO2019177135A1 (ja) * 2018-03-15 2021-03-18 テルモ株式会社 シート状細胞培養物の製造方法
TWI741263B (zh) 2018-03-15 2021-10-01 日商泰爾茂股份有限公司 片狀細胞培養物的製造方法
EP3811983B1 (en) 2018-06-12 2023-10-25 Kyoto University Composition for cell transplant, and method for cell transplant
SG11202007242UA (en) 2018-07-27 2020-08-28 Univ Nagasaki Sheet-shaped cell culture for regeneration of digestive tract
JPWO2020067442A1 (ja) 2018-09-27 2021-08-30 テルモ株式会社 細胞の凍結保存方法
EP3739040B1 (en) 2018-09-27 2023-07-05 Osaka University Sheeting method for pluripotent stem cell-derived cells
JP6657452B2 (ja) * 2019-02-27 2020-03-04 テルモ株式会社 シート状細胞培養物の製造方法
JP7002497B2 (ja) * 2019-06-20 2022-01-20 テルモ株式会社 シート状細胞培養物の製造方法
EP4026587A4 (en) 2019-09-30 2022-11-16 TERUMO Kabushiki Kaisha METHOD OF INCREASING THE PERCENTAGE OF CD56+ CELLS
CN114364784B (zh) 2019-09-30 2024-02-02 泰尔茂株式会社 试样的粉碎方法
WO2021076454A1 (en) * 2019-10-16 2021-04-22 Wisconsin Alumni Research Foundation Mechanically stable and high cell density honeycomb retinal scaffold design for transplantation therapy of photoreceptor cells and retinal pigment epithelium
EP4046642A4 (en) * 2019-10-17 2022-12-21 TERUMO Kabushiki Kaisha CELL CULTURE FOR THE TREATMENT OF INFLAMMATORY DISEASES
US20210189327A1 (en) * 2019-12-24 2021-06-24 Mcmaster University 3d stimulated tissue constructs and methods of making thereof
CN113498434A (zh) * 2020-01-22 2021-10-12 京东方科技集团股份有限公司 间充质干细胞膜片及其用途
JP6872051B2 (ja) * 2020-02-05 2021-05-19 テルモ株式会社 シート状細胞培養物の製造方法
JP2024511064A (ja) 2021-03-23 2024-03-12 テルモ ビーシーティー、インコーポレーテッド 細胞捕獲及び増殖
TW202306575A (zh) 2021-06-23 2023-02-16 日商Ａｄｅｋａ股份有限公司 去細胞化細胞結構體
CN118525083A (zh) 2022-01-14 2024-08-20 国立大学法人大阪大学 用于处置肝功能障碍的片状细胞培养物
WO2023136313A1 (ja) 2022-01-14 2023-07-20 国立大学法人大阪大学 肝機能障害を処置するための組成物

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH06104061B2 (ja) 1989-02-10 1994-12-21 花王株式会社 細胞培養支持体材料
JP2777678B2 (ja) 1990-06-11 1998-07-23 敏一 中村 組換ヒト肝実質細胞増殖因子及びその製造方法
JPH05192138A (ja) * 1992-01-22 1993-08-03 Kao Corp 皮膚細胞培養法及び培養皮膚
US6432711B1 (en) * 1993-11-03 2002-08-13 Diacrin, Inc. Embryonic stem cells capable of differentiating into desired cell lines
US5618718A (en) 1994-12-30 1997-04-08 Universite Laval Production of a contractile smooth muscle
US6207451B1 (en) * 1998-09-15 2001-03-27 The Regents Of The University Of Michigan Mammalian muscle construct and method for producing same
WO2001007568A2 (en) * 1999-07-23 2001-02-01 Diacrin, Inc. Muscle cells and their use in cardiac repair
JP4389008B2 (ja) 1999-11-09 2009-12-24 独立行政法人産業技術総合研究所 有機ゲル複合化球形無機多孔質粒子およびその製造方法
JP4431233B2 (ja) 1999-11-30 2010-03-10 テルモ株式会社 ハニカム構造体およびその調製方法、ならびにその構造体を用いたフィルムおよび細胞培養基材
JP2001213992A (ja) 2000-01-31 2001-08-07 Japan Chemical Innovation Institute 感温性多孔質高分子ゲル粒子及びその製造方法
DE60143892D1 (de) * 2000-07-21 2011-03-03 Cellseed Ind Herzmuskel-ähnliche zellschicht, dreidimensionales konstrukt, herzmuskel-ähnliches gewebe und verfahren zur herstellung
JP2002233567A (ja) * 2000-12-06 2002-08-20 Mitsuo Ochi 移植用組織等価物及びその製造方法
JP2002335949A (ja) 2001-05-22 2002-11-26 Inst Of Physical & Chemical Res ハニカム構造体フィルムを用いた細胞の三次元組織培養法
WO2003007795A2 (en) * 2001-07-16 2003-01-30 Edwards Lifesciences Corporation Tissue engineered heart valve
JP3599701B2 (ja) * 2001-11-15 2004-12-08 独立行政法人理化学研究所 立体構造物表面への細胞生着法
FR2833610B1 (fr) 2001-12-14 2007-01-26 Natural Implant Construits cellulaires cultives in vitro, preparation et utilisations

Also Published As

Publication number Publication date
JP2015033637A (ja) 2015-02-19
JP2007528755A (ja) 2007-10-18
DK2266499T3 (da) 2015-06-29
US20150110756A1 (en) 2015-04-23
US9587222B2 (en) 2017-03-07
ES2540242T3 (es) 2015-07-09
ES2535087T3 (es) 2015-05-05
EP2266499B1 (en) 2015-06-10
EP1659979A1 (en) 2006-05-31
WO2005011524A1 (en) 2005-02-10
EP2266500B1 (en) 2015-04-01
EP1659979B1 (en) 2015-04-01
EP2266499A2 (en) 2010-12-29
EP2266500A3 (en) 2011-09-14
US20070092492A1 (en) 2007-04-26
JP2010029680A (ja) 2010-02-12
EP2266500A2 (en) 2010-12-29
JP4943844B2 (ja) 2012-05-30
EP2266499A3 (en) 2011-09-14
JP2012139541A (ja) 2012-07-26

Similar Documents

Publication Publication Date Title
DK2266500T3 (da) Tredimensionel vævstruktur
DE602004026245D1 (de) Endoskop
DE602004021746D1 (de) Endoskop
DE50306910D1 (de) Dreidimensionale knotenstruktur
ATE389374T1 (de) Zwischenwirbelimplantat
DE112004000739B8 (de) Chirurgischer Retraktor
DE602004007220D1 (de) Verbinder
DE602004031798D1 (de) Verbinder
DE602004006494D1 (de) Trittbrett
DE602004022898D1 (de) Verbinder
SE0303324L (sv) Implantat
DE602004016877D1 (de) Untersuchungsstuhl
DE602004026397D1 (de) Verbinder
DE602004004176D1 (de) Arbeitsgerät
DK1597171T3 (da) Terapeutisk mikroskum
FI20031750A0 (fi) Mammografialaite
DE602004000627D1 (de) Hautreinigungsmittel
NO20034599L (no) Brokonstruksjon
NO20034600D0 (no) Brokonstruksjon
DE602004003978D1 (de) Verbinder
SE0303322L (sv) Implantat
DE60316553D1 (de) Verbinder
DE602004009500D1 (de) Verbinder
DE602004029309D1 (de) Verbinder
FIU20030143U0 (fi) Vaappu